From: Design and implementation of a novel pharmacogenetic assay for the identification of the CYP2D6*10 genetic variant
Samples (n = 70)
Genotype Frequency n (%)
Major allele frequency (%)
Minor allele frequency (%)
Hormone receptor positive breast cancer patients
CC
CT
TT
C
T
17 (24.3%)
53 (75.7%)
0
0.6214 (62.1%)
0.3786 (37.9%)